Taking into consideration the significant role of TGF-β1 in the pathogenesis of myocardial fibrosis, it can be suggested that the HDAC inhibitor Rhein could become a potential therapeutic approach for MI-induced cardiac fibrosis. The gene discussed is TGFB1; the disease is myocardial infarction.